LoriYepKamMD

PubMed

• 61 citations
  Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease.
  Maria T. Abreu, Jordan L. Geller, Eric A. Vasiliauskas, Lori Y. Kam, Puja Vora, Lenna A. Martyak, Huiying Yang, Bei Hu, Ying Chao Lin, Gregory Keenan, Joanne Price, Ca...> ;Journal of Clinical Gastroenterology. 2006 Jan 1
• 72 citations
  An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial.
  Douglas L. Seidner, Bret A. Lashner, Aaron Brzezinski, Phillip L.C. Banks, John R. Goldblum, Claudio Fiocchi, Jeffry Katz, Gary R. Lichtenstein, Peter A. Anton, Lori Y...> ;Clinical Gastroenterology and Hepatology. 2005 Apr 1
• Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.
  Abreu, M.T., Taylor, K.D., Lin, Y., Hang, T., Gaiennie, J., Landers, C.J., Vasiliauskas, E.A., Kam, L.Y., Rojany, M., Papadakis, K.A., Rotter, J.I., Targan, S.R., Yang...> ;Gastroenterology. 2002 Sep
• 386 citations
  6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.
  Marla Dubinsky, Huiying Yang, Philip V. Hassard, Ernest G. Seidman, Lori Y. Kam, Maria T. Abreu, Stephan R. Targan, Eric A. Vasiliauskas> ;Gastroenterology. 2002 Apr 1
• 116 citations
  An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.
  Marla Dubinsky, Philip V. Hassard, Ernest G. Seidman, Lori Y. Kam, Maria T. Abreu, Stephan R. Targan, Eric A. Vasiliauskas> ;Inflammatory Bowel Diseases. 2001 Aug 1
• 32 citations
  TNF-alpha antagonists for the treatment of Crohn's disease.
  Lori Y. Kam, Stephan R. Targan> ;Expert Opinion on Pharmacotherapy. 2000 May 1
• 43 citations
  Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
  Philip V. Hassard, Eric A. Vasiliauskas, Lori Y. Kam, Stephan R. Targan, Maria T. Abreu> ;Inflammatory Bowel Diseases. 2000 Feb 1
• 162 citations
  Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
  Nikolaos A. Tountas, Vincenzo Casini–Raggi, Huiying Yang, Francesco S. di Giovine, Maurizio Vecchi, Lori Kam, Lorenzo Melani, Theresa T. Pizarro, Jerome I. Rotter, Fab...> ;Gastroenterology. 1999 Oct 1
• 17 citations
  Cytokine-based therapies in inflammatory bowel disease.
  Lori Y. Kam, Stephan R. Targan> ;Current Opinion in Gastroenterology. 1999 Jul 1
• 24 citations
  Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications.
  Katherine Facklis, Scott E. Plevy, Eric A. Vasiliauskas, Lori Kam, Kent D. Taylor, Stephan R. Targan, Phillip Fleshner> ;Diseases of the Colon and Rectum. 1999 May 1
• 1 citations
  ULCERATIVE COLITIS IN YOUNG ADULTS: COMPLEXITIES OF DIAGNOSIS AND MANAGEMENT
  Lori Kam> ;Postgraduate Medicine. 1998 Jan 1
• 316 citations
  Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
  Vincenzo Casini-Raggi, Lori Kam, Yoo Jin T Chong, Claudio Fiocchi, Theresa T. Pizarro, Fabio Cominelli> ;Journal of Immunology. 1995 Mar 1
• Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies. A host factor in homosexual HIV-1 transmission.
  Townsley-Fuchs, J., Kam, L., Fairhurst, R., Gange, S. J., Goodglick, L., Giorgi, J. V., Sidell, N., Detels, R., Braun, J.> ;J Clin Invest. 1996 Oct 15
• 45 citations
  A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
  L Kam, H Cohen, C Dooley, P Rubin, J Orchard> ;The American Journal of Gastroenterology. 1996 Jul 1
• Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.
  Papadakis, K. A., Tung, J. K., Binder, S. W., Kam, L. Y., Abreu, M. T., Targan, S. R., Vasiliauskas, E. A.> ;Am J Gastroenterol. 2001 Jul
• High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ...
  Fleshner, P. R., Vasiliauskas, E. A., Kam, L. Y., Fleshner, N. E., Gaiennie, J., Abreu-Martin, M. T., Targan, S. R.> ;Gut. 2001 Nov
• An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.
  Vasiliauskas, E. A., Kam, L. Y., Abreu-Martin, M. T., Hassard, P. V., Papadakis, K. A., Yang, H., Zeldis, J. B., Targan, S. R.> ;Gastroenterology. 1999 Dec
• Marker antibody expression stratifies Crohn''s disease into immunologically homogeneous subgroups with distinct clinical characteristics.
  Vasiliauskas, E. A., Kam, L. Y., Karp, L. C., Gaiennie, J., Yang, H., Targan, S. R.> ;Gut. 2000 Oct
• Join now to see all